nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement
|
|
|
2012 |
35 |
12 |
p. 1081-1084 |
artikel |
2 |
Acknowledgement
|
|
|
2012 |
35 |
12 |
p. 1081-1084 |
artikel |
3 |
Balancing the Risks and Benefits of the Use of Over-the-Counter Pain Medications in Children
|
Arencibia, Zeina Bárzaga |
|
2012 |
35 |
12 |
p. 1119-1125 |
artikel |
4 |
Balancing the Risks and Benefits of the Use of Over-the-Counter Pain Medications in Children
|
Arencibia, Zeina Bárzaga |
|
2012 |
35 |
12 |
p. 1119-1125 |
artikel |
5 |
Communicating the New Pharmacovigilance Landscape
|
Edwards, I. Ralph |
|
2012 |
35 |
12 |
p. 1085-1089 |
artikel |
6 |
Communicating the New Pharmacovigilance Landscape
|
Edwards, I. Ralph |
|
2012 |
35 |
12 |
p. 1085-1089 |
artikel |
7 |
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis
|
Baldessarini, Ross J. |
|
2012 |
35 |
12 |
p. 1183 |
artikel |
8 |
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis
|
Baldessarini, Ross J. |
|
2012 |
35 |
12 |
p. 1183 |
artikel |
9 |
Current Challenges and Controversies in Drug-Induced Liver Injury
|
Corsini, Alberto |
|
2012 |
35 |
12 |
p. 1099-1117 |
artikel |
10 |
Current Challenges and Controversies in Drug-Induced Liver Injury
|
Corsini, Alberto |
|
2012 |
35 |
12 |
p. 1099-1117 |
artikel |
11 |
First Workshop on Computational Methods in Pharmacovigilance held during the Medical Informatics in Europe (MIE) Conference, Pisa, Italy, 29 August 2012
|
|
|
2012 |
35 |
12 |
p. 1191-1200 |
artikel |
12 |
First Workshop on Computational Methods in Pharmacovigilance held during the Medical Informatics in Europe (MIE) Conference, Pisa, Italy, 29 August 2012
|
|
|
2012 |
35 |
12 |
p. 1191-1200 |
artikel |
13 |
Global Patterns of Adverse Drug Reactions Over a Decade
|
Aagaard, Lise |
|
2012 |
35 |
12 |
p. 1171-1182 |
artikel |
14 |
Global Patterns of Adverse Drug Reactions Over a Decade
|
Aagaard, Lise |
|
2012 |
35 |
12 |
p. 1171-1182 |
artikel |
15 |
How to Improve Communication for the Safe Use of Medicines?
|
Bahri, Priya |
|
2012 |
35 |
12 |
p. 1073-1079 |
artikel |
16 |
How to Improve Communication for the Safe Use of Medicines?
|
Bahri, Priya |
|
2012 |
35 |
12 |
p. 1073-1079 |
artikel |
17 |
Individual NSAIDs and Upper Gastrointestinal Complications
|
Castellsague, Jordi |
|
2012 |
35 |
12 |
p. 1127-1146 |
artikel |
18 |
Individual NSAIDs and Upper Gastrointestinal Complications
|
Castellsague, Jordi |
|
2012 |
35 |
12 |
p. 1127-1146 |
artikel |
19 |
Internet Accounts of Serious Adverse Drug Reactions
|
Butt, Tehreem F. |
|
2012 |
35 |
12 |
p. 1159-1170 |
artikel |
20 |
Internet Accounts of Serious Adverse Drug Reactions
|
Butt, Tehreem F. |
|
2012 |
35 |
12 |
p. 1159-1170 |
artikel |
21 |
Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
|
Jones, Mark |
|
2012 |
35 |
12 |
p. 1187-1188 |
artikel |
22 |
Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
|
Jones, Mark |
|
2012 |
35 |
12 |
p. 1187-1188 |
artikel |
23 |
Olanzapine in Schizophrenia and Affective Disorders
|
Undurraga, Juan |
|
2012 |
35 |
12 |
p. 1185-1186 |
artikel |
24 |
Olanzapine in Schizophrenia and Affective Disorders
|
Undurraga, Juan |
|
2012 |
35 |
12 |
p. 1185-1186 |
artikel |
25 |
Reasons for and Time to Discontinuation of Rimonabant Therapy
|
Willemen, Marjolein J. C. |
|
2012 |
35 |
12 |
p. 1147-1158 |
artikel |
26 |
Reasons for and Time to Discontinuation of Rimonabant Therapy
|
Willemen, Marjolein J. C. |
|
2012 |
35 |
12 |
p. 1147-1158 |
artikel |
27 |
Suspected Herbal Hepatotoxicity
|
Teschke, Rolf |
|
2012 |
35 |
12 |
p. 1091-1097 |
artikel |
28 |
Suspected Herbal Hepatotoxicity
|
Teschke, Rolf |
|
2012 |
35 |
12 |
p. 1091-1097 |
artikel |
29 |
The Authors’ Reply
|
Toovey, Stephen |
|
2012 |
35 |
12 |
p. 1188-1190 |
artikel |
30 |
The Authors’ Reply
|
Stip, Emmanuel |
|
2012 |
35 |
12 |
p. 1183-1184 |
artikel |
31 |
The Authors’ Reply
|
Stip, Emmanuel |
|
2012 |
35 |
12 |
p. 1186 |
artikel |
32 |
The Authors’ Reply
|
Stip, Emmanuel |
|
2012 |
35 |
12 |
p. 1183-1184 |
artikel |
33 |
The Authors’ Reply
|
Toovey, Stephen |
|
2012 |
35 |
12 |
p. 1188-1190 |
artikel |
34 |
The Authors’ Reply
|
Stip, Emmanuel |
|
2012 |
35 |
12 |
p. 1186 |
artikel |